(Q33859986)

29 July 2017

1 reference

title

Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies (English)

1 reference

29 July 2017

1 reference

Remick SC

1

1 reference

29 July 2017

Sedransk N

2

1 reference

29 July 2017

Haase R

3

1 reference

29 July 2017

Craffey M

4

1 reference

29 July 2017

Subramanian N

5

1 reference

29 July 2017

Dowlati A

6

1 reference

29 July 2017

Nazeer T

7

1 reference

29 July 2017

Ramnes C

8

1 reference

29 July 2017

Blanchard C

9

1 reference

29 July 2017

Mastrianni D

10

1 reference

29 July 2017

Balducci L

11

1 reference

29 July 2017

Horton J

12

1 reference

29 July 2017

Ruckdeschel JC

13

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58 Suppl 3

1 reference

29 July 2017

page(s)

99-107

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958003-00014

29 July 2017

exact match

0 references

cites work

Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours

1 reference

12 December 2020

Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia

1 reference

12 December 2020

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

12 December 2020

Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.

1 reference

12 December 2020

Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men

1 reference

12 December 2020

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

12 December 2020

Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.

1 reference

12 December 2020

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

1 reference

12 December 2020

Etoposide (VP-16-213)

1 reference

12 December 2020

Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS

1 reference

12 December 2020

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1 reference

12 December 2020

Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Oral etoposide in lymphoma

1 reference

12 December 2020

Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL)

1 reference

12 December 2020

Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.

1 reference

12 December 2020

Risk of infectious complications in patients taking glucocorticosteroids

1 reference

12 December 2020

Cyclophosphamide: Use in Practice

1 reference

12 December 2020

Acquired Immunodeficiency Syndrome-Related Non-Hodgkin Lymphoma

1 reference

12 December 2020

Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential

1 reference

12 December 2020

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

1 reference

12 December 2020

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

12 December 2020

Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature

1 reference

12 December 2020

BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma

1 reference

12 December 2020

HIV-associated Hodgkin's disease. Biologic and clinical aspects

1 reference

12 December 2020

1 reference

12 December 2020

Acquired immunodeficiency syndrome-associated lymphomas

1 reference

12 December 2020

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

12 December 2020

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial

1 reference

12 December 2020

1 reference

12 December 2020

Drugs 5 years later: procarbazine

1 reference

12 December 2020

Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

1 reference

12 December 2020

Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma

1 reference

12 December 2020

Steroid-induced Kaposi's sarcoma in a patient with pre-AIDS.

1 reference

12 December 2020

Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review

1 reference

12 December 2020

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

12 December 2020

Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

10.2165/00003495-199958003-00014

Identifiers

DOI

0 references

Dimensions Publication ID

1035346700

0 references

1 reference